Question 1

Is Olmesartan/Amlodipino/Hidroclorotiazida Cinfa currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Olmesartan/Amlodipino/Hidroclorotiazida Cinfa has 26 active shortage notices across 5 countries (Spain, Belgium, Netherlands, Ireland, Malaysia). Status is refreshed daily from official regulatory sources.

Question 2

Why is Olmesartan/Amlodipino/Hidroclorotiazida Cinfa in shortage?

Accepted Answer

Regulators attribute the current Olmesartan/Amlodipino/Hidroclorotiazida Cinfa shortages to supply-chain disruption, manufacturing problems, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Olmesartan/Amlodipino/Hidroclorotiazida Cinfa shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 30 Mar 2026 to 20 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Olmesartan/Amlodipino/Hidroclorotiazida Cinfa shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Spain	high	7	6 Mar 2025	20 Sept 2026	AEMPS
Belgium	medium	12	5 May 2025	17 Jun 2026	FAMHP
Netherlands

Olmesartan/Amlodipino/Hidroclorotiazida Cinfa shortage status

Where Olmesartan/Amlodipino/Hidroclorotiazida Cinfa is in shortage

Why Olmesartan/Amlodipino/Hidroclorotiazida Cinfa is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Olmesartan/Amlodipino/Hidroclorotiazida Cinfa status changes